The world's thirteenth leading cause of death, tuberculosis (TB) is a bacterial infection caused by the bacterium "Mycobacterium tuberculosis" that primarily affects the lungs. The disease is spread by airborne transmission when a sick person coughs, spits or sneezes tubercle bacilli into the air that another person inhales.
La pandémie est loin d’être terminée. À la fin de l’année 2021, seuls cinq pays africains (Cap-Vert, Île Maurice, Maroc, Seychelles et Tunisie), soit moins de 10 % des 54 nations africaines, devaient atteindre l’objectif de vaccination complète de 40 % de leur population.
The pandemic is far from over. At the end of 2021, only five African countries (Cabo Verde, Mauritius, Morocco, Seychelles, and Tunisia), less than 10% of Africa’s 54 nations, were projected to hit the target of fully vaccinating 40% of their population. In the absence of wide scale vaccine rollouts, the continent must continue to rely on the tried and tested non-pharmaceutical interventions that have proved impactful in managing the outbreak until this point.
Dans un communiqué de presse le 6 octobre 2021, l’Organisation mondiale de la Santé (OMS) a approuvé l’utilisation du vaccin antipaludique RTS,S/AS01.
In a press release on October 6, 2021, the World Health Organization (WHO) approved the use of the malaria vaccine RTS,S/AS01. This landmark achievement is based on the success of the pilot vaccination programs in three countries in the WHO African Region (WHO/AFRO) that are Ghana, Kenya and Malawi.